To unequivocally demonstrate the functional role of the Jag1-ICD signaling in CRC drug resistance, we firstly analyzed Jagged1 processing in HCT15 and DLD1 cells upon OXP and 5FU treatments. The gene discussed is JAG1; the disease is colorectal carcinoma.